Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Industry / United Kingdom

GlaxoSmithKline's Centre Of Excellence For External Drug Discovery Invests In Prosensa

October 2009 | Industry Trend Analysis

Following UK drugmaker GlaxoSmithKline (GSK)'s Centre of Excellence for External Drug Discovery (CEEDD)'s June 2009 alliance with Chroma Therapeutics, the company's drug discovery centre has signed a deal with Dutch-based biopharmaceutical company, Prosensa for the development and commercialisation of RNA-based therapeutics for Duchenne Muscular Dystrophy (DMD).

To read the full article, please choose one of the following options:

Subcribers please log in

Western Europe InsightWestern Europe Channels Western Europe Countries